Nu Skin Enterprises (NUS) Given a $88.00 Price Target by Citigroup Analysts

Citigroup set a $88.00 price objective on Nu Skin Enterprises (NYSE:NUS) in a report released on Thursday. The brokerage currently has a buy rating on the stock.

Other research analysts also recently issued reports about the company. Jefferies Financial Group set a $98.00 price target on Nu Skin Enterprises and gave the stock a buy rating in a research report on Friday, August 3rd. Stifel Nicolaus raised Nu Skin Enterprises from a sell rating to a hold rating and lifted their price target for the stock from $57.00 to $70.00 in a research report on Thursday, August 2nd. They noted that the move was a valuation call. Zacks Investment Research downgraded Nu Skin Enterprises from a hold rating to a sell rating in a research report on Tuesday, October 23rd. Finally, DA Davidson began coverage on Nu Skin Enterprises in a research report on Tuesday, October 9th. They issued a buy rating and a $92.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company’s stock. Nu Skin Enterprises has a consensus rating of Buy and an average target price of $86.29.

NYSE NUS traded up $2.18 during trading on Thursday, hitting $65.02. The company’s stock had a trading volume of 583,550 shares, compared to its average volume of 463,815. The company has a quick ratio of 1.19, a current ratio of 1.82 and a debt-to-equity ratio of 0.46. The company has a market cap of $4.04 billion, a P/E ratio of 20.13, a P/E/G ratio of 1.78 and a beta of 1.04. Nu Skin Enterprises has a 52 week low of $60.60 and a 52 week high of $88.68.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, November 7th. The company reported $0.94 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.96 by ($0.02). The business had revenue of $675.31 million during the quarter, compared to the consensus estimate of $664.99 million. Nu Skin Enterprises had a return on equity of 25.67% and a net margin of 5.74%. The business’s quarterly revenue was up 19.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.76 earnings per share. Sell-side analysts expect that Nu Skin Enterprises will post 3.59 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Friday, November 30th will be given a $0.365 dividend. This represents a $1.46 annualized dividend and a yield of 2.25%. The ex-dividend date of this dividend is Thursday, November 29th. Nu Skin Enterprises’s dividend payout ratio is currently 45.20%.

In other news, General Counsel D Matthew Dorny sold 2,500 shares of Nu Skin Enterprises stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $82.18, for a total transaction of $205,450.00. Following the sale, the general counsel now owns 33,871 shares of the company’s stock, valued at approximately $2,783,518.78. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 5.20% of the stock is currently owned by company insiders.

Several large investors have recently made changes to their positions in NUS. BlackRock Inc. grew its holdings in shares of Nu Skin Enterprises by 11.5% during the 2nd quarter. BlackRock Inc. now owns 6,143,407 shares of the company’s stock worth $480,352,000 after purchasing an additional 635,246 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. grew its holdings in shares of Nu Skin Enterprises by 410.1% during the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 427,800 shares of the company’s stock worth $35,259,000 after purchasing an additional 343,935 shares in the last quarter. Renaissance Technologies LLC grew its holdings in shares of Nu Skin Enterprises by 51.1% during the 2nd quarter. Renaissance Technologies LLC now owns 814,000 shares of the company’s stock worth $63,647,000 after purchasing an additional 275,200 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Nu Skin Enterprises by 524.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 295,551 shares of the company’s stock worth $24,359,000 after purchasing an additional 248,222 shares in the last quarter. Finally, Acadian Asset Management LLC grew its holdings in shares of Nu Skin Enterprises by 112.2% during the 2nd quarter. Acadian Asset Management LLC now owns 368,804 shares of the company’s stock worth $28,834,000 after purchasing an additional 194,990 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Featured Story: How to Invest in Marijuana Stocks

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply